Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by goldwatch69on Nov 13, 2018 4:23pm

115 Views

Post# 28967964

Cannacord likes NF

Recent Trades - Last 10 of 230

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:56:23	C	0.085		17,000	33 Canaccord	7 TD Sec	K
15:56:23	C	0.09	0.005	3,000	33 Canaccord	1 Anonymous	K
15:56:23	U	0.085		5,000	33 Canaccord	99 Jitney	K
15:56:23	U	0.085		15,000	33 Canaccord	13 Instinet	K
15:56:23	C	0.085		12,000	33 Canaccord	1 Anonymous	K
15:56:23	C	0.085		51,000	33 Canaccord	1 Anonymous	K
15:56:23	C	0.085		1,000	33 Canaccord	1 Anonymous	K
15:56:23	C	0.085		13,000	33 Canaccord	1 Anonymous	K
15:56:23	C	0.085		12,000	33 Canaccord	1 Anonymous	K
15:56:23	C	0.085		83,000	33 Canaccord	7 TD Sec	K